Vycor Medical (VYCO) Shares Outstanding (Weighted Average) (2011 - 2026)

Vycor Medical (VYCO) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $33.4 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $33.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.4 million (changed 0.0% YoY) and the FY2025 annual result came in at $33.4 million, up 1.48% from the prior year.
• Shares Outstanding (Weighted Average) was little changed at $33.4 million in Q1 2026 per VYCO's latest filing, from $33.4 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $33.4 million in Q1 2025 and bottomed at $30.8 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $32.6 million (2023), against an average of $32.6 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) climbed 10.75%; it then changed 0.0% in 2024.
• Tracing VYCO's Shares Outstanding (Weighted Average) over 5 years: stood at $31.7 million in 2022, then rose by 2.82% to $32.6 million in 2023, then rose by 0.86% to $32.9 million in 2024, then climbed by 1.48% to $33.4 million in 2025, then changed by 0.0% to $33.4 million in 2026.
• Per Business Quant, the three latest VYCO Shares Outstanding (Weighted Average) figures stand at $33.4 million (Q1 2026), $33.4 million (Q4 2025), and $33.4 million (Q3 2025).

Peer Comparison